Customs Processing Services Named New Executive Leadership
The firm added three executives to oversee operations and lead a new division focused on advanced molecular separation.
Updated on Sept. 20, 2026 in People
Customs Processing Services appointed Albert S. Medoro as president, Carl J. Fiorini II as chief operating officer, and Ken Zrebiec as president of CPS Purifications. These management changes aim to support the company's expansion into specialized chemical and molecular technologies.
Why it matters
These leadership appointments signal a shift toward internal reorganization and technical expansion for the firm. By installing dedicated oversight for operational safety and new molecular separation technologies, the company is positioning itself to scale its niche processing capabilities.
The new executive team brings a combined 30 years of technical expertise to the firm, including 24 years of pharmaceutical industry experience from Ken Zrebiec and 14 years of operational tenure from Carl J. Fiorini II.
The players
Customs Processing Services
A company specializing in industrial processing and chemical services.
Albert S. Medoro
The new president of Customs Processing Services who holds a B.S. in business management and marketing.
Carl J. Fiorini II
The new chief operating officer focused on operational safety and accountability.
Ken Zrebiec
The new president of CPS Purifications and former pharmaceutical industry executive.
The details
The internal management transition installs specific oversight for operations, accountability, and communication under Fiorini. Simultaneously, Zrebiec will build a new division focused on advanced molecular separation technologies. This structural change targets improvements in internal safety protocols while diversifying the company's technological service offerings.
Timeline
September 20, 2026: Executive appointments were officially announced.
Market Landscape
The firm’s move to establish a division for advanced molecular separation technologies follows the historical trend of industrial firms diversifying into pharmaceutical-grade purification. This leadership expansion marks a departure from traditional processing to more specialized, tech-driven output.
Operators should monitor whether these leadership shifts result in increased service capacity for complex chemical processing. Changes in operational safety and accountability metrics under the new COO may serve as a bellwether for the company's reliability with high-stakes client projects.
The takeaway
Management transitions often precede changes in service quality and technical capabilities for specialized processors. Review your own key vendor contracts to see if changes in their internal leadership structure might affect their core operating focus in the coming fiscal year.
Further reading
For more on shifts in corporate oversight and executive transitions, explore the People section.
Source note: This article includes information reported by Reading Eagle.
